Cumberland Pharmaceuticals Appoints Rick S. Greene as Vice President, Finance & Accounting

Cumberland Pharmaceuticals Inc. a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Rick S. Greene, a long-time financial advisor to the Company, has been appointed interim Vice President, Finance & Accounting effective April 5, 2011. Mr. Greene has more than 20 years of experience in financial management and reporting. He previously served as Chief Financial Officer at Surgical Alliance Corporation, a specialty hospital company, and Director of Financial Operations at Phycor, Inc., a publicly held physician management company. He also has held positions at the national accounting firms Ernst & Young and Crowe Horwath.

Mr. Greene is the Market Leader for Crowe Horwath's Tennessee healthcare practice, where he has developed and led a financial advisory team serving private equity firms, technology, pharmaceutical and other healthcare companies. Mr. Greene and his team supported Cumberland's accounting department in the preparation of the Company's Initial Public Offering, as well as Cumberland's ongoing financial statement preparation and SEC reporting.

David L. Lowrance, who has been serving as Cumberland's Vice President, Finance & Accounting and Chief Financial Officer, will transition out of that role as he pursues interests outside of the Company following his acceptance of an appointment at a private healthcare company.

"We welcome and support Rick in his new role and are fortunate that we are able to draw on his depth of knowledge and experience with our Company," said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. "We are grateful for Dave's contributions to the Company and wish him well in his new endeavors. We believe that this is an appropriate time for such a transition, following the completion and filing of our 2010 audited financials as well as the conclusion of our first Sarbanes-Oxley audit."